Pharmacotherapy of aphasia: myth or reality?

Details

Serval ID
serval:BIB_178E451F1FD4
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Pharmacotherapy of aphasia: myth or reality?
Journal
Brain and Language
Author(s)
de Boissezon X., Peran P., de Boysson C., Démonet J.F.
ISSN
0093-934X (Print)
ISSN-L
0093-934X
Publication state
Published
Issued date
2007
Peer-reviewed
Oui
Volume
102
Number
1
Pages
114-125
Language
english
Notes
Publication types: Journal Article ; ReviewPublication Status: ppublish. PDF type: Brief communication
Abstract
Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents. Here, we reviewed the MEDLINE available reports of drug therapy for aphasia. So far, proofs of efficiency were found indubitable for none of the studied molecules. However, some of them showed limited efficiency (piracetam and amphetamine). Moreover, drug therapies for aphasia were less efficient alone than when they were associated with speech therapy.
Keywords
Amphetamine/therapeutic use, Aphasia/drug therapy, Aphasia/etiology, Bromocriptine/therapeutic use, Cholinesterase Inhibitors/therapeutic use, Clinical Trials as Topic, Dopamine Agents/therapeutic use, Fluoxetine/therapeutic use, GABA Agonists/therapeutic use, Humans, Indans/therapeutic use, Neuroprotective Agents/therapeutic use, Paroxetine/therapeutic use, Physostigmine/therapeutic use, Piperidines/therapeutic use, Piracetam/therapeutic use, Pyridines/therapeutic use, Serotonin/therapeutic use, Serotonin Uptake Inhibitors/therapeutic use, Stroke/complications
Pubmed
Web of science
Create date
24/03/2013 18:52
Last modification date
20/08/2019 12:47
Usage data